ACG Wealth’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

ACG Wealth’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-281	Closed	–	–	1092
2022 Q2	$0	Buy	+281	New	+$1.29K	﹤0.01%	1114

Other funds holding CORZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PFO

Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

SFS

Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return

JWM

JGP Wealth Management Bend, Oregon $1.11B AUM 35.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ACG Wealth's CORZ Position: Q3 2022 in Review

ACG Wealth sold out of Core Scientific, Inc. Common Stock (CORZ) in Q3 2022, closing a stake of 281 shares.

ACG Wealth first reported a position in CORZ in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 137 funds tracked by Wall St. Rank hold CORZ as of Q3 2022.

ACG Wealth reported no remaining Core Scientific, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
ACG Wealth sold 281 Core Scientific, Inc. Common Stock shares in Q3 2022.
ACG Wealth first reported a position in Core Scientific, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
ACG Wealth's Core Scientific, Inc. Common Stock position peaked at $0 in Q2 2022.
137 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q3 2022.

Based on ACG Wealth's 13F filing for Q3 2022, filed 3 Nov 2022.